From: Interconnectivity between molecular subtypes and tumor stage in colorectal cancer
Total | MATCH cohort | GSE33113 | |||||
---|---|---|---|---|---|---|---|
n = 197 | n = 112 | n = 85 | |||||
Gender | Female | 101 | 51.3% | 57 | 50.9% | 44 | 51.8% |
Male | 96 | 48.7% | 55 | 49.1% | 41 | 48.2% | |
Age | Median (IQR) | 71.0 (63.0–77.0) | 70.0 (63.0–76.0) | 74.6 (61.9–80.2) | |||
T | 3 | 184 | 93.4% | 107 | 95.5% | 77 | 90,6% |
4 | 13 | 6.6% | 5 | 4.5% | 8 | 9.4% | |
N | Median (range) | 14 | (1–46) | 14 | (5–28) | 12 | (1–46) |
N | < 10 lymph nodes assesed | 45 | 22.8% | 14 | 12.5% | 31 | 36.5% |
≥ 10 lymph nodes assesed | 142 | 72.1% | 98 | 87.5% | 44 | 51.8% | |
Missing | 10 | 5.1% | 0 | 0,0% | 10 | 11.8% | |
MSI | MSS | 140 | 71.1% | 79 | 70.5% | 61 | 71.8% |
MSI | 52 | 26.4% | 28 | 25.0% | 24 | 28.2% | |
Missing | 5 | 2.5% | 5 | 4.5% | 0 | 0.0% | |
CMS | 1 | 49 | 24.9% | 29 | 25.9% | 20 | 23.5% |
2 | 83 | 42.1% | 52 | 46.4% | 31 | 36.5% | |
3 | 19 | 9.6% | 11 | 9.8% | 8 | 9.4% | |
4 | 20 | 10.2% | 5 | 4.5% | 15 | 17,6% | |
Indeterminate | 26 | 13.2% | 15 | 13.4% | 11 | 12.9% |